{"pmid":32376774,"title":"Impact of COVID-19 pandemic on SLE: beyond the risk of infection.","text":["Impact of COVID-19 pandemic on SLE: beyond the risk of infection.","Lupus Sci Med","Horisberger, Alice","Moi, Laura","Ribi, Camillo","Comte, Denis","32376774"],"journal":"Lupus Sci Med","authors":["Horisberger, Alice","Moi, Laura","Ribi, Camillo","Comte, Denis"],"date":"2020-05-08T11:00:00Z","year":2020,"_id":"32376774","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1136/lupus-2020-000408","keywords":["antirheumatic agents","interferon type i","lupus erythematosus, systemic"],"topics":["Prevention"],"weight":1,"_version_":1666597097416163328,"score":9.490897,"similar":[{"pmid":32327429,"title":"Can hydroxychloroquine protect patients with rheumatic diseases from COVID-19? Response to: 'Does hydroxychloroquine prevent the transmission of COVID-19?' by Heldwein and Calado and 'SLE, hydroxychloroquine and no SLE patients with COVID-19: a comment' by Joob and Wiwanitkit.","text":["Can hydroxychloroquine protect patients with rheumatic diseases from COVID-19? Response to: 'Does hydroxychloroquine prevent the transmission of COVID-19?' by Heldwein and Calado and 'SLE, hydroxychloroquine and no SLE patients with COVID-19: a comment' by Joob and Wiwanitkit.","Ann Rheum Dis","Monti, Sara","Montecucco, Carlomaurizio","32327429"],"journal":"Ann Rheum Dis","authors":["Monti, Sara","Montecucco, Carlomaurizio"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32327429","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1136/annrheumdis-2020-217524","keywords":["antirheumatic agents","hydroxychloroquine","lupus erythematosus, systemic"],"locations":["Calado"],"e_drugs":["Hydroxychloroquine"],"topics":["Treatment"],"weight":1,"_version_":1666138494562467844,"score":108.097664},{"pmid":32451344,"title":"Are patients with systemic lupus erythematosus at increased risk for COVID-19?","text":["Are patients with systemic lupus erythematosus at increased risk for COVID-19?","Ann Rheum Dis","Favalli, Ennio Giulio","Gerosa, Maria","Murgo, Antonella","Caporali, Roberto","32451344"],"journal":"Ann Rheum Dis","authors":["Favalli, Ennio Giulio","Gerosa, Maria","Murgo, Antonella","Caporali, Roberto"],"date":"2020-05-27T11:00:00Z","year":2020,"_id":"32451344","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1136/annrheumdis-2020-217787","keywords":["antirheumatic agents","hydroxychloroquine","lupus erythematosus, systemic"],"topics":["Prevention"],"weight":1,"_version_":1667983494599409664,"score":84.71755},{"pmid":32434820,"title":"Hydroxychloroquine shortages during the COVID-19 pandemic.","text":["Hydroxychloroquine shortages during the COVID-19 pandemic.","Ann Rheum Dis","Mendel, Arielle","Bernatsky, Sasha","Thorne, J Carter","Lacaille, Diane","Johnson, Sindhu R","Vinet, Evelyne","32434820"],"journal":"Ann Rheum Dis","authors":["Mendel, Arielle","Bernatsky, Sasha","Thorne, J Carter","Lacaille, Diane","Johnson, Sindhu R","Vinet, Evelyne"],"date":"2020-05-22T11:00:00Z","year":2020,"_id":"32434820","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1136/annrheumdis-2020-217835","keywords":["antirheumatic agents","autoimmune diseases","epidemiology","hydroxychloroquine","lupus erythematosus, systemic"],"e_drugs":["Hydroxychloroquine"],"topics":["Prevention"],"weight":1,"_version_":1667521393556717568,"score":78.99205},{"pmid":32327426,"title":"SLE patients are not immune to covid-19: importance of sending the right message across.","text":["SLE patients are not immune to covid-19: importance of sending the right message across.","Ann Rheum Dis","Goyal, Mohit","32327426"],"journal":"Ann Rheum Dis","authors":["Goyal, Mohit"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32327426","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1136/annrheumdis-2020-217658","keywords":["autoimmune diseases","communicable diseases, imported","epidemiology","hydroxychloroquine","lupus erythematosus, systemic"],"topics":["Treatment"],"weight":1,"_version_":1666138494668374016,"score":73.09777},{"pmid":32295787,"title":"SLE, hydroxychloroquine and no SLE patients with covid-19: a comment.","text":["SLE, hydroxychloroquine and no SLE patients with covid-19: a comment.","Ann Rheum Dis","Joob, Beuy","Wiwanitkit, Viroj","32295787"],"journal":"Ann Rheum Dis","authors":["Joob, Beuy","Wiwanitkit, Viroj"],"date":"2020-04-17T11:00:00Z","year":2020,"_id":"32295787","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1136/annrheumdis-2020-217506","keywords":["immune complex diseases","inflammation","lupus erythematosus systemic"],"e_drugs":["Hydroxychloroquine"],"topics":["Treatment"],"weight":1,"_version_":1666138493263282176,"score":55.11806}]}